85 related articles for article (PubMed ID: 28825787)
21. Abundant distribution of TARP gamma-8 in synaptic and extrasynaptic surface of hippocampal neurons and its major role in AMPA receptor expression on spines and dendrites.
Fukaya M; Tsujita M; Yamazaki M; Kushiya E; Abe M; Akashi K; Natsume R; Kano M; Kamiya H; Watanabe M; Sakimura K
Eur J Neurosci; 2006 Oct; 24(8):2177-90. PubMed ID: 17074043
[TBL] [Abstract][Full Text] [Related]
22. Protein complexes as psychiatric and neurological drug targets.
Kato AS; Witkin JM
Biochem Pharmacol; 2018 May; 151():263-281. PubMed ID: 29330067
[TBL] [Abstract][Full Text] [Related]
23. Selective loss of AMPA receptor subunits at inhibitory neuron synapses in the cerebellum of the ataxic stargazer mouse.
Shevtsova O; Leitch B
Brain Res; 2012 Jan; 1427():54-64. PubMed ID: 22055455
[TBL] [Abstract][Full Text] [Related]
24. 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.
Szymańska E; Pickering DS; Nielsen B; Johansen TN
Bioorg Med Chem; 2009 Sep; 17(17):6390-401. PubMed ID: 19656686
[TBL] [Abstract][Full Text] [Related]
25. Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein
Yamasaki T; Ishii H; Hiraishi A; Kumata K; Wakizaka H; Zhang Y; Kurihara Y; Ogawa M; Nengaki N; Chen J; Li Y; Liang S; Zhang MR
J Cereb Blood Flow Metab; 2023 Jun; 43(6):893-904. PubMed ID: 36655318
[TBL] [Abstract][Full Text] [Related]
26. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
27. Relative contribution of TARPs γ-2 and γ-7 to cerebellar excitatory synaptic transmission and motor behavior.
Yamazaki M; Le Pichon CE; Jackson AC; Cerpas M; Sakimura K; Scearce-Levie K; Nicoll RA
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):E371-9. PubMed ID: 25583485
[TBL] [Abstract][Full Text] [Related]
28. Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins.
Tomita S; Chen L; Kawasaki Y; Petralia RS; Wenthold RJ; Nicoll RA; Bredt DS
J Cell Biol; 2003 May; 161(4):805-16. PubMed ID: 12771129
[TBL] [Abstract][Full Text] [Related]
29. 3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: molecular modeling and pharmacological studies.
Colotta V; Lenzi O; Catarzi D; Varano F; Squarcialupi L; Costagli C; Galli A; Ghelardini C; Pugliese AM; Maraula G; Coppi E; Pellegrini-Giampietro DE; Pedata F; Sabbadin D; Moro S
Eur J Med Chem; 2012 Aug; 54():470-82. PubMed ID: 22704999
[TBL] [Abstract][Full Text] [Related]
30. Stargazin Modulation of AMPA Receptors.
Shaikh SA; Dolino DM; Lee G; Chatterjee S; MacLean DM; Flatebo C; Landes CF; Jayaraman V
Cell Rep; 2016 Oct; 17(2):328-335. PubMed ID: 27705782
[TBL] [Abstract][Full Text] [Related]
31. Stargazin and AMPA receptor membrane expression is increased in the somatosensory cortex of Genetic Absence Epilepsy Rats from Strasbourg.
Kennard JT; Barmanray R; Sampurno S; Ozturk E; Reid CA; Paradiso L; D'Abaco GM; Kaye AH; Foote SJ; O'Brien TJ; Powell KL
Neurobiol Dis; 2011 Apr; 42(1):48-54. PubMed ID: 21220022
[TBL] [Abstract][Full Text] [Related]
32. Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.
More JC; Troop HM; Dolman NP; Jane DE
Br J Pharmacol; 2003 Mar; 138(6):1093-100. PubMed ID: 12684265
[TBL] [Abstract][Full Text] [Related]
33. TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating.
Milstein AD; Zhou W; Karimzadegan S; Bredt DS; Nicoll RA
Neuron; 2007 Sep; 55(6):905-18. PubMed ID: 17880894
[TBL] [Abstract][Full Text] [Related]
34. A novel action of stargazin as an enhancer of AMPA receptor activity.
Yamazaki M; Ohno-Shosaku T; Fukaya M; Kano M; Watanabe M; Sakimura K
Neurosci Res; 2004 Dec; 50(4):369-74. PubMed ID: 15567474
[TBL] [Abstract][Full Text] [Related]
35. TARPs differentially decorate AMPA receptors to specify neuropharmacology.
Kato AS; Gill MB; Yu H; Nisenbaum ES; Bredt DS
Trends Neurosci; 2010 May; 33(5):241-8. PubMed ID: 20219255
[TBL] [Abstract][Full Text] [Related]
36. Differential localization and regulation of stargazin-like protein, gamma-8 and stargazin in the plasma membrane of hippocampal and cortical neurons.
Inamura M; Itakura M; Okamoto H; Hoka S; Mizoguchi A; Fukazawa Y; Shigemoto R; Yamamori S; Takahashi M
Neurosci Res; 2006 May; 55(1):45-53. PubMed ID: 16516319
[TBL] [Abstract][Full Text] [Related]
37. Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.
Pentikäinen U; Settimo L; Johnson MS; Pentikäinen OT
Org Biomol Chem; 2006 Mar; 4(6):1058-70. PubMed ID: 16525550
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
[TBL] [Abstract][Full Text] [Related]
39. The interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking.
Bats C; Groc L; Choquet D
Neuron; 2007 Mar; 53(5):719-34. PubMed ID: 17329211
[TBL] [Abstract][Full Text] [Related]
40. A Comment on "Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8".
Witkin JM; Gardinier KM
J Pharmacol Exp Ther; 2016 Sep; 358(3):502-3. PubMed ID: 27528544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
